Introduction
Hip fractures represent a significant public health concern, often leading to disability, reduced quality of life, and increased mortality, particularly in the elderly population. As the global population ages, the incidence of hip fractures is expected to rise dramatically. By 2025, the worldwide number of hip fractures is projected to reach 2.6 million, increasing further to 6.25 million by 2050 (1–3).
Trochanteric fractures involve the proximal femur, specifically the region between the femoral neck and the shaft. Subtrochanteric fractures, characterized by a fracture line extending up to 5 cm distal to the lesser trochanter, are often included in this definition. Various classification systems exist for trochanteric fractures, typically based on the location of the fracture line and the degree of displacement, which impacts external reduction techniques (4–7). Two widely recognized classifications are the Evans classification, later modified by Jensen and Michaelsen, and the AO/OTA Classification. The Evans classification categorizes fractures based on stability, ranging from non-displaced two-fragment fractures (Type I) to more complex comminuted fractures involving medial and posterolateral displacement. The AO/OTA Classification, developed by the AO Foundation and adopted by the Orthopaedic Trauma Association, further aids in the classification of these injuries. (8–13).
Trochanteric fractures are frequently addressed surgically, with sliding hip screws (SHS) and intramedullary nails (IMN) being the two most widely used fixation techniques (14). Although many studies report no significant differences in outcomes between these methods, this may be attributed to including all types of trochanteric fractures in the analysis. Recent research tends to focus on stable and unstable fracture categories without detailed consideration of the specific AO/OTA subtypes (31A1, 31A2, 31A3), which could make findings more clinically relevant (15–17). Current guidelines, such as the Dutch Guideline, recommend extramedullary fixation for AO 31-A1 and 31-A2 fractures due to their superior cost-effectiveness, mainly driven by lower implant costs. Nonetheless, extramedullary and intramedullary fixation is acceptable for 31-A2 fractures, with no definitive evidence supporting one method over the other. Earlier studies, particularly those evaluating first-generation cephalomedullary nails, raised concerns about higher failure and reoperation rates with intramedullary devices. Despite this, the use of IMN has increased significantly in recent years, accounting for up to 90% of procedures in the US, as recent data indicates better outcomes. However, this growing preference may also be influenced by factors other than purely clinical outcomes, leaving the best treatment approach a subject of ongoing debate (18,19,19–23).
The objective of this study was to evaluate the intraoperative and postoperative differences between intramedullary nailing and dynamic hip screw fixation in patients with trochanteric fractures compare between the results of the most recent evidence and the previous published meta-analysis.
Methods
2.1 Data Sources and Search Strategy
This study adhered to the recommendations set forth by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement and the Cochrane Handbook for Systematic Reviews of Interventions. A comprehensive literature search was performed across PubMed, Scopus, Web of Science, and the Cochrane Library databases, covering publications up to September 2024. The specific search strategies employed for each database can be found in Supplementary File 1. The study protocol was registered in the international prospective register of systematic reviews, PROSPERO (CRD42024583373)
2.2 Eligibility Criteria and Selection Process
We included the clinical trials and observational comparative studies published in English till September 2024 and have an accessible full text focusing on the patients with trochanteric fractures who underwent IMN Vs. DHS. However, we excluded studies that were animal-based, laboratory-based, basic science, cadaveric, editorial, or published in languages other than English.
Based on the previous specific criteria, two authors independently reviewed each study’s title and abstract in the prescreening process and the full text in the whole text screening process to ensure that all included studies met the inclusion criteria.
2.3 Data extraction tool and items
Another four authors were responsible for data extraction using an Excel spreadsheet. Two authors extracted a summary of the included studies, including the following items: title, study design, site, population, intervention, comparator, follow-up duration (in weeks) and sample size. The other two authors extracted baseline demographics and outcomes reported in the included studies, which included age, BMI, sex, fracture classification, American Society of Anesthesiologists (ASA) score, and side of fracture.
2.4 Outcomes measurement
Primary outcomes: open reduction of fracture, blood loose (ml), time to healing (days) and femoral neck shortening (mm)
Secondary outcomes: required blood transfusion (UNITS), Patients need Blood transfusion, screening time (min), mean surgical time (min), hospital stay (days), mean Harris hip score and mobility score and Parker Mobility Score
2.5 Quality assessment
The quality of the randomized control trials (RCTs) was assessed independently by two authors using The Cochrane Collaboration’s tool for assessing the risk of bias (ROB-1) (24) and the cohort studies included were evaluated by another two authors using the Newcastle-Ottawa Scale (NOS) (25).
2.6 Statistical analysis
The meta-analysis was conducted using Stata 17, employing mean difference (MD) or standardized mean difference (SMD) effect sizes for continuous outcomes and log odds-ratio effect size for binary outcomes. A random-effects model was utilized to account for study heterogeneity. Statistical significance was determined with a p-value of less than 0.05 and a 95% confidence interval (95% CI). Heterogeneity was considered significant if I² was greater than 50% and the p-value was below 0.1. Subgroup analyses were performed based on study design, and meta-regression was used to assess covariates' impact, such as age and gender. Additionally, trial sequential analysis (TSA) (26) and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) (27) were employed to evaluate the robustness and overall quality of the evidence for the primary outcomes.
2.7 Publication bias
Publication bias across all outcomes was evaluated using funnel plot visualization and egger test (28).
Results
3.1 Study Selection and Data Extraction
The initial search retrieved 3,740 research papers. After removing 540 duplicates, 3,200 papers remained for title and abstract screening. After excluding 3,061 studies, 139 papers entered the full-text screening process. Based on the prespecified inclusion and exclusion criteria, we included 60 studies in the final analysis, which comprised 31 randomized controlled trials (RCTs) and 29 cohort studies. The total number of participants is 88256 patients, ranging from 39 in the most minor cohort study to 34759 in the largest cohort studies, with follow-up periods varying from 1 to 212 weeks. This process is presented in Supplementary file 1. The summary of the studies included is presented in Table 1 and the baseline characteristics is presented in Supplementary file 1.
| study ID | title | design | site | population | Intervention | comparator | follow up (weeks) | sample size |
|---|---|---|---|---|---|---|---|---|
| Adams 2001 | Prospective randomized controlled trial of an intramedullary nail versus dynamic screw and plate for intertrochanteric fractures of the femur | RCT | UK | patients admitted from the local population with intertrochanteric fractured femurs | GN | DHS | 48 | 400 |
| Adeel 2020 | Comparison of proximal femoral nail (PFN) and dynamic hip screw (DHS) for the treatment of AO type A2 and A3 pertrochanteric fractures of femur | RCT | Pakistan | patients aged 40-75 years with Arbeitsgemeinschaft für Osteosynthesefragen type A2 and A3 per trochanteric fractures | PFN | DHS | 48 | 68 |
| Ahmad 2019 | Injury specific trauma registry: Outcomes of a prospective cohort with proximal femur fractures | Prospective Cohort | Pakistan | Patients with isolated neck of femur or intertrochanteric fractures between 2015 and 2018 at Aga Khan University | IMN | DHS | 52 | 138 |
| Ahrengart 2002 | A randomized study of the compression hip screw and Gamma nail in 426 fractures | RCT | Sweden, Finland | Four hundred twenty-six patients with intertrochanteric fractures | GN | DHS | 24 | 426 |
| Aktselis 2014 | Prospective randomised controlled trial of an intramedullary nail versus a sliding hip screw for intertrochanteric fractures of the femur | RCT | Greece | patients with a 31-A2.2 or A2.3 Arbeitsgemeinschaft für Osteosynthesefragen/Orthopaedic Trauma Association (AO/OTA) intertrochanteric fracture | GN | DHS | 48 | 71 |
| Arshad 2021 | Dynamic hip screw fxation of subtrochanteric femoral fractures | Retrospective cohort | UK | 86 patients presented with a subtrochanteric fracture of the femur | IMN | DHS | - | 86 |
| Avakian 2011 | Dynamic hip screws versus proximal femoral nails for intertrochanteric fractures | Retrospective cohort | Australia | 144 patients with intertrochanteric fractures | PFN | DHS | - | 144 |
| Barton 2010 | A comparison of the long gamma nail with the sliding hip screw for the treatment of AO/OTA 31-A2 fractures of the proximal part of the femur: a prospective randomized trial | RCT | UK | Two hundred and ten patients presenting with an AO/OTA 31-A2 fracture of the proximal part of the femur | GN | DHS | 48 | 210 |
| Berney 2024 | Is the increased use of intramedullary nailing over DHS for intertrochanteric hip fractures justified? – A review of the Irish hip fracture database 2016 –2020 | Retrospective cohort | Ireland | Patients with intertrochanteric fractures older than 60 years | DHS | IMN | - | 5668 |
| Butt 1995 | Comparison of dynamic hip screw and gamma nail: a prospective, randomized, controlled trial | RCT | UK | 95 consecutive pafients with peri-trochnteric fractures of the femur. | GN | DHS | - | 95 |
| Carruli 2017 | A comparison of two fixation methods for femoral trochanteric fractures: a new generation intramedullary system vssliding hip screw | RCT | Switzerland | patients affected by a trochanteric fracture, treated between January 2007 to December 2009 | PFNA | DHS | 12 | 128 |
| Chau 2013 | Cephalomedullary nail versus sliding hip screw for unstable intertrochanteric fractures in elderly patients | cohort | Singapore | 63 elderly patients aged ≥60 years with unstable intertrochanteric fractures (AO types A2 and A3) | PFNA | DHS | 48 | 63 |
| Chen 2013 | Convergence of Outcomes for Hip Fracture Fixation by Nails and Plates | Retrospective cohort | USA | patients who sustained a hip fracture by the International Classification of Diseases | IMN | DHS | 48 | 8924 |
| Das 2020 | Osteosynthesis of intertrochanteric fracturesby PFN and DHS – A prospective randomized comparative study | RCT | India | 150 patients of unstable ITF (AO type 31-A2, 31-A3) in elderly (with age more than 50 years) | PFN | DHS | 48 | 150 |
| Duan 2017 | Comparison of the curative effects of PFNA and DHS fixation in treating intertrochanteric fractures in elderly patients | Retrospective cohort | China | Patients aged between 60-92 years old admitted with intertrochanteric fractures | PFNA | DHS | 78 | 108 |
| Dunne 2021 | Comparison of outcomes after different methods of fixation for extracapsular hip fractures: An observational study | Retrospective cohort | England | Patients with stable and unstable hip fractures | PFNA | DHS | 52 | 1335 |
| Gawronska 2022 (Aug) | Holistic Symmetry Assessment Using Pedobarography after Treatment of Pertrochanteric Fractures in Elderly Patients | Prospective cohort | Poland | Elderly patients aged 65+ with pertrochanteric fractures | IMN | DHS | 36 | 60 |
| Gawronska 2022 (Feb) | Functional Symmetry after Surgical Treatment of Pertrochanteric Fractures in the Elderly | Prospective cohort | Poland | Adults with pertrochanteric femoral fractures. | IMN | DHS | 24 | 78 |
| Grezda 2021 | Comparison of systemic inflammatory responses of proximal femoral nail versus dynamic hip screw after treatment of patients with pertrochanteric fractures: A prospective comparative study | Prospective cohort | Kosovo | patients older than 60 with trochanteric region fractures AO/OTA 31.A1–31.A2 | DHS | PFN | 1 | 40 |
| Hardy 1998 | Use of an intramedullary hip-screw compared with a compression hip-screw with a plate for intertrochanteric femoral fractures. A prospective, randomized study of one hundred patients | RCT | Belgium | elderly patients who had an intertrochanteric femoral fracture | GN | DHS | 48 | 100 |
| Harrington 2002 | Intramedullary hip screw versus sliding hip screw for unstable intertrochanteric femoral fractures in the elderly | RCT | UK | patients with unstable trochanteric fractures above 65 years of age, without a previous proximal femoral fracture | IMN | DHS | 48 | 102 |
| Hoffman 1996 | Intertrochanteric fractures of the femur: a randomized prospective comparison of the Gamma nail and the Ambi hip screw | RCT | New Zealand | patients over the age of 50 years with intertrochanteric femoral fractures | GN | DHS | 96 | 67 |
| Huang 2017 | Comparison of the Clinical Effectiveness of PFNA, PFLCP, and DHS in Treatment of Unstable Intertrochanteric Femoral Fracture | RCT | China | patients with unstable intertrochanteric femoral fracture were extracted from the archived records at the department of orthopedics of Linyi Second People’s Hospital | PFNA | DHS | 96 | 60 |
| Kassem 2022 | Functional and radiological outcomes of dynamic hip screw with trochanteric stabilizing plate versus short proximal femoral nail in management of unstable trochanteric fractures: A randomized-controlled trial | RCT | Egypt | patients above the age of 60 years with isolated unstable trochanteric fractures (AO/OTA 31-A2). | PFN | DHS+TSP | 52 | 68 |
| Kim 2020 | Single screw type of lag screw results higher reoperation rate in the osteosynthesis of basicervical hip fracture | Retrospective cohort | South Korea | Patients with basicervical hip fracture of the proximal part of the femur | CMN | DHS | 104 | 106 |
| Kim 2022 | What Is the Best Treatment Choice for Concomitant Ipsilateral Femoral Neck and Intertrochanteric Fracture? A Retrospective Comparative Analysis of 115 Consecutive Patients | Retrospective cohort | Republic of Korea | Patients diagnosed with concomitant ipsilateral femoral neck and intertrochanteric fractures (CIFNITF) who underwent surgical treatment. | PFN-A | DHS | 48 | 84 |
| Kleftouris 2023 | Endovis Nail versus Dynamic Hip Screw for Unstable Pertrochanteric Fractures: A Feasibility Randomised Control Trial including Patients with Cognitive Impairment | RCT | Helsinki | 60 consecutive patients with an unstable pertrochanteric (OTA/AO 31-A2) fracture | IMN | DHS | 12 | 60 |
| Konda 2021 | Risk Stratification of Operatively Treated Intertrochanteric Hip Fractures Reveals Differences in Short-Term Outcomes and Procedure Costs Between Sliding Hip Screw Versus Short Cephalomedullary Nail | Retrospective cohort | USA | Geriatric patients (aged 55 years and older) with intertrochanteric hip fractures | short CMN | SHS | 48 | 458 |
| Kumar 2011 | Comparative prospective study of proximal femoral nail and dynamic hip screw in treatment of intertrochanteric fracture femur | Prospective cohort | India | cases of intertrochanteric fractures of the femur, involving patients more than 50 years old | PFN | DHS | 48 | 50 |
| Little 2008 | A prospective trial comparing the Holland nail with the dynamic hip screw in the treatment of intertrochanteric fractures of the hip | RCT | UK | patients who presented with an extra-capsular intertrochanteric hip fracture | Holland Nail | DHS | 48 | 190 |
| Marks 2021 | Quality of life, walking ability and change of living situation after trochanteric femur fracture in geriatric patients-Comparison between sliding hip screw and cephalomedullary nails from the registry for geriatric trauma | Retrospective cohort | Germany | patients treated hip fractures between 2016 and 2019 | CMN | SHS | 17 | 10995 |
| Mazzola 2022 | Dynamic hip screw versus intramedullary nailing for the treatment of A1 intertrochanteric fractures: A retrospective, comparative study and cost analysis | Retrospective Cohort | Italy | patients experiencing emergency department diagnosis of proximal femoral fracture in January 1st, 2015 and December 31st, 2019. | IMN | DHS | 201 | 85 |
| Pajarinen 2004 | Femoral shaft medialisation and neck-shaft angle in unstable pertrochanteric femoral fractures | RCT | Switzerland | patients with an unstable, low-energy, extracapsular, pertrochanteric femoral fracture (AO category 31-A, class A2) | PFN | DHS | 16 | 48 |
| Pajarinen 2005 | Pertrochanteric femoral fractures treated with a dynamic hip screw or a proximal femoral nail. A randomised study comparing post-operative rehabilitation | RCT | Finland | patients with a pertrochanteric femoral fracture | PFN | DHS | 16 | 108 |
| Parker 2012 | Sliding hip screw versus the Targon PF nail in the treatment of trochanteric fractures of the hip: a randomised trial of 600 fractures | RCT | UK | 598 patients with 600 trochanteric fractures of the hip | Targon PF | DHS | 48 | 600 |
| Parker 2017 | Sliding hip screw versus intramedullary nail for trochanteric hip fractures; a randomised trial of 1000 patients with presentation of results related to fracture stability | RCT | UK | patients with stable (A1), unstable (A2), and transtrochanteric (A3) fractures, excluding pathological and subtrochanteric fractures. | IMN | SHS | - | 1000 |
| Parker-Cawley 2017 | Sliding hip screw versus the Targon PFT nail for trochanteric hip fractures: a randomised trial of 400 patients | RCT | UK | patients with trochanteric hip fractures | Targon PF | DHS | 48 | 400 |
| Pehli̇Vanoğlu 2021 | Proximal femoral nailing versus dynamic hip screw in management of stable intertrochanteric femur fractures: a comparison of clinical and radiological outcomes | Retrospective Cohort | turkey | Patients who underwent surgical treatment for a SIFF in the department | PFNA | DHS | 24 | 122 |
| Reindl 2015 | Intramedullary Versus Extramedullary Fixation for Unstable Intertrochanteric Fractures: A Prospective Randomized Controlled Trial | RCT | Canada | patients aged 55 and older with Type-A2 intertrochanteric fractures | IMN | DHS | 48 | 194 |
| Saarenpää 2006 | Treatment of subtrochanteric fractures. A comparison of the Gamma nail and the dynamic hip screw: short-term outcome in 58 patients | Cohort | Finland | 1,511 patients with 1,624 femoral hip fractures, aged over 49 years, treated between 1991 and 1999. | GN | DHS | 52 | 58 |
| Sadowski 2002 | Treatment of Reverse Oblique and Transverse Intertrochanteric Fractures with Use of an Intramedullary Nail or a 95° Screw-Plate | RCT | Switzerland | elderly patients with AO/OTA 31-A3 intertrochanteric femur fractures | PFN | DCH | 48 | 39 |
| Sahin 2012 | Dynamic hip screw versus proximal femoral nail for treatment of trochanteric hip fractures: an outcome analyses with a minimum 2 years of follow-up | Retrospective Cohort | Turkey | patients who underwent surgery for extracapsular pertrochanteric hip fractures between 2005 and 2010 | PFNA | DHS | 96 | 181 |
| Saleem 2020 | Comparison of unstable inter-trochanteric femur fracture treated with Dynamic Hip Screw and Proximal Femur Nail | RCT | Pakistan | Patients aged 40-80 years with radiological evidence of unstable inter-trochanteric fracture not more than three weeks old and willing to provide informed consent | PFN | DHS | 24 | 108 |
| Sanders 2017 | A Multicenter Randomized Control Trial Comparing a Novel Intramedullary Device (InterTAN) Versus Conventional Treatment (Sliding Hip Screw) of Geriatric Hip Fractures | RCT | Canada | Two hundred forty-nine patients 55 years of age or older with AO/OTA 31A1 (43) and OA/OTA 31A2 (206) fractures were prospectively enrolled and followed for 12 months. | InterTAN | DHS | 48 | 249 |
| Saudan 2002 | Pertrochanteric fractures: is there an advantage to an intramedullary nail?: a randomized, prospective study of 206 patients comparing the dynamic hip screw and proximal femoral nail | RCT | Switzerland | All patients over the age of fifty-five years presenting with fractures of the trochanteric region caused by a lowenergy injury, classified as AO/OTA Type 31-A1 and A2 | PFN | DHS | 48 | 206 |
| Schemitsch 2023 | Intramedullary Nailing vs Sliding Hip Screw in Trochanteric Fracture Management: The INSITE Randomized Clinical Trial | RCT | INSITE Investigators | patients aged 18 years and older with low-energy trochanteric fractures (AO/OTA type 31-A1 or 31-A2) | IMN | DHS | 52 | 833 |
| Singh 2019 | Is PFNA-II a better implant for stable intertrochanteric fractures in elderly population ? A prospective randomized study | RCT | India | elderly patients with stable intertrochanteric fractures treated with DHS and PFNA-II between August 2014 to Dec 2016 | PFNA | DHS | 48 | 60 |
| Talmac 2019 | Examining implant superiority in the treatment of simple pertrochanteric fractures of the proximal femur in elderly patients | Retrospective Cohort | turkey | elderly patients diagnosed with simple pertrochanteric fractures (AO/OTA 31A1) | PFNA | DHS | 52 | 141 |
| tarantino 2005 | A comparative prospective study of dynamic variable angle hip screw and Gamma nail in intertrochanteric hip fractures | Prospective cohort | Italy | patients with AO/OTA Type 31-A1; A2; A3 and B2 intertrochanteric hip fractures | GN | DMS | 52 | 142 |
| Tian 2022 | A Retrospective Study of 98 Elderly Patients with High-Risk Lateral Femoral Wall Intertrochanteric Hip Fractures to Compare Outcomes Following Surgery with Proximal Femoral Nail Antirotation (PFNA) Versus Dynamic Hip Screw (DHS) | Retrospective Cohort | China | patients with high-risk intertrochanteric fractures of the lateral wall who underwent surgery from January 2019 to December 2020 | PFNA | DHS | 26 | 98 |
| Utrilla 2005 | Trochanteric gamma nail and compression hip screw for trochanteric fractures: a randomized, prospective, comparative study in 210 elderly patients with a new design of the gamma nail | RCT | Spain | patients older than 65 years with trochanteric femoral fractures | GN | DHS | 48 | 210 |
| Warren 2019 | Cephalomedullary nailing versus sliding hip screws for Intertrochanteric and basicervical hip fractures: a propensity-matched study of short-term outcomes in over 17,000 patients | Retrospective Cohort | US | patients with a BC femoral neck fracture or a peritrochanteric hip fracture | CMN | SHS | 4 | 17000 |
| Werner 2015 | Trends in the management of intertrochanteric femur fractures in the United States 2005-2011 | Retrospective cohort | Nationwide database of Medicare patients | Patients with proximal femur fractures from 2005 to 2011 | IMN | SHS | - | 34759 |
| Xu 2010 | A comparison of the proximal femoral nail antirotation device and dynamic hip screw in the treatment of unstable pertrochanteric fracture | RCT | China | patients with unstable proximal femoral fractures (AO category 31-A2) admitted to a hospital between August 2006 and June 2008. | PFNA | DHS | 48 | 106 |
| Yeganeh 2016 | Comparing the Intramedullary Nailing Method Versus Dynamic Hip Screw in Treatment of Unstable Intertrochanteric Fractures | Retrospective cohort | Iran | patients with unstable Intertrochanteric fracture | PFN | DHS | 24 | 114 |
| Yu 2016 | Proximal femoral nails anti-rotation versusdynamic hip screws for treatment of stable intertrochanteric femur fractures: an outcome analyses with a minimum 4 yearsof follow-up | Retrospective cohort | China | patients age of 60–92 years, good cognitive function, a stable IFF(type AO/ OTA 31.A1.1, 1.2, 1.3) | PFNA | DHS | 212 | 222 |
| Zang 2018 | A comparative study of proximal femoral locking compress plate, proximal femoral nail antirotation and dynamic hip screw in intertrochanteric fractures | Retrospective cohort | china | patients with intertrochanteric femur fractures admitted between January 2015 and December 2016 | PFNA | DHS | 26 | 100 |
| Zehir 2015 | Proximal femoral nail antirotation against dynamic hip screw for unstable trochanteric fractures; a prospective randomized comparison | RCT | Turkey | Patients with AO type 31.A2 fracture on plain radiographs and aged above 65 years | PFNA | DHS | 24 | 198 |
| zeng 2017 | Proximal femoral nail antirotation versus dynamic hip screw fixation for treatment of osteoporotic type 31-A1 intertrochanteric femoral fractures in elderly patients | Retrospective cohort | China | Patients aged 60–92 years with osteoporotic 31-A1 intertrochanteric femoral fractures | PFNA | DHS | 48 | 222 |
| Zou 2009 | A comparison of proximal femoral nail antirotation and dynamic hip screw devices in trochanteric fractures | RCT | China | patients with low-energy trochanteric femoral fractures | PFNA | DHS | 48 | 121 |
3.2 Quality assessment
The quality assessment of the included RCTs indicates a generally high methodological rigor. Specifically, 24 of 31 RCTs received a "high quality" rating (29–52). Six studies were rated "moderate quality" (53–58), indicating some potential limitations in methodology. Only one study was rated "low" (59) suggesting more significant methodological concerns that could affect the study's reliability. Supplementary file 1.
The quality assessment of the included cohort studies reveals a strong overall standard. Out of the 29 studies evaluated, 26 received a "Good" rating (60–85), while three studies were rated as "Fair" (86–88). The "Fair" rating indicates the presence of some methodological limitations that may affect the reliability or generalizability of the findings. Supplementary file 1.
3.3 Intraoperative differences
The meta-analysis revealed the following results: For open reduction of fracture, the log odds ratio was -1.52 (95% CI [-3.31; 0.28], I² = 86.07%, p-value = 0.10), indicating no statistically significant difference Figure 1A. Regarding the need for blood transfusions, the log odds ratio was -0.65 (95% CI [-1.40; 0.09], I² = 95.85%, p-value = 0.09), suggesting a trend favoring IMN, though not statistically significant Figure 1B. The analysis also revealed a mean difference of -0.06 units (95% CI [-0.14; 0.03], I² = 21.05%, p-value = 0.18) for required blood transfusions, indicating minimal clinical relevance Figure 1C. Screening time was slightly longer for IMN, with a mean difference of 0.52 minutes (95% CI [0.03; 1.02], I² = 99.75%, p-value < 0.05) Figure 1D. In terms of blood loss, IMN showed a significant reduction with a mean difference of -98.80 ml (95% CI [-127.96; -69.64], I² = 99.51%, p-value < 0.01), demonstrating a clear advantage for this technique in minimizing intraoperative hemorrhage Figure 2. Finally, the mean surgical time favored IMN with a significant reduction of -9.47 minutes (95% CI [-14.15; -4.80], I² = 98.79%, p-value < 0.01) Figure 3.
3.4 Postoperative differences
In terms of hospital stay, IMN demonstrated a slight advantage over DHS fixation, with a significant standardized mean difference of -0.22 (95% CI [-0.33; -0.10], I² = 90.71%, p < 0.01), indicating a modest reduction in hospital days for IMN patients Figure 4. For time to healing, IMN showed a statistically significant improvement with a mean difference of -6.92 days (95% CI [-12.55; -1.29], I² = 95.04%, p = 0.02), suggesting a quicker recovery period compared to DHS Figure 5A. However, no significant difference was observed in femoral neck shortening, with a mean difference of -1.19 mm (95% CI [-4.21; 1.83], I² = 99.76%, p = 0.44) Figure 5B. Mean PMS did not differ significantly between IMN and DHS, with a standardized mean difference of 0.18 (95% CI [-0.17; 0.53], I² = 85.30%, p = 0.31), indicating comparable functional outcomes for both techniques Figure 5C. Similarly, mean HHS did not differ significantly, with a standardized mean difference of 0.01 (95% CI [-0.70; 0.72], I² = 97.41%, p = 0.97) Figure 6.
3.5 Subgroup analysis
In the subgroup analysis by study design (RCTs vs. NRCTs), no statistically significant differences were observed between RCTs and NRCTs across most outcomes. Specifically, tests of subgroup differences outcomes such as open reduction of fracture (p = 0.11) Supplementary File 1, blood loss (p = 0.74) Supplementary File 1, patients needing blood transfusion (p = 0.58) Supplementary File 1, mean surgical time (p = 0.24) Supplementary File 1, hospital stay (p = 0.89) Supplementary File 1, mean HHS (p = 0.36) Supplementary File 1, and healing time (p = 0.89) showed similar results between RCTs and NRCTs, with p-values consistently above the 0.05 threshold, indicating non-significance Supplementary File 1. An exception was noted in screening time, where results reached statistical significance for RCTs (p = 0.0) but remained non-significant for NRCTs (p = 0.5) Supplementary File 1. This suggests that study design may influence specific outcomes, such as screening time, but overall, the effect of IMN versus DHS did not substantially differ based on the study design.
3.6 Sensitivity analysis
The sensitivity analysis, conducted using a leave-one-out test, provided valuable insights into the robustness of the meta-analysis. In most cases, removing individual studies did not significantly change the overall results, indicating stability in the findings. However, certain studies did have an impact on specific outcomes. For open reduction of the fracture, statistical significance favoring IMN over DHS (p = 0.029) was observed only after excluding the study by Kassem et al. (2022) Supplementary File 1. Blood loss (ml) demonstrated consistent nonsignificant results across all iterations, with no single study exclusion altering the overall findings Supplementary File 1. Patients requiring blood transfusion showed a statistically significant advantage for IMN (p = 0.01) exclusively after omitting Werner et al. (2015) Supplementary File 1. Conversely, required blood transfusion units remained unaffected by any study exclusion Supplementary File 1. Screening time (min) exhibited heterogeneity; removing specific studies (Utrilla, 2005; Saudan, 2002; Parker, 2012; Singh, 2019; Tarantino, 2005; Talmac, 2019) individually yielded p-values < 0.05, indicating these trials collectively influenced the pooled effect's significance Supplementary File 1. Mean surgical time (min) and hospital stay (days) maintained nonsignificant results regardless of excluded studies Supplementary File 1. Time to healing (days) was only not statistically significant AFTER excluding Huang 2017 (p= 0.051) Supplementary File 1. Femoral neck shortening (mm) achieved statistical significance (p = 0.026) solely after excluding Harrington et al. (2002) Supplementary File 1. Notably, HHS and PMS remained stable, with no single-study exclusion impacting their overall results Supplementary File 1.
3.7 Cumulative analysis
The cumulative analysis revealed several important trends. Initially, while IMN demonstrated significant benefits over DHS for specific outcomes, such as open reduction of fractures, the significance and magnitude of these effects tended to diminish as more studies, particularly Kassem 2022, were included Supplementary File 2. Regarding blood loss, the evidence favoring IMN became statistically significant after incorporating Little 2008 (p = 0.011), with subsequent studies further reinforcing this trend Supplementary File 2. For patients needing blood transfusions, earlier studies supported IMN significantly; however, the addition of more recent studies diluted this significance Supplementary File 2. The analysis also showed that the statistical significance for required blood transfusion units emerged after including Pajarinen 2005 (p = 0.006), but again, it was lost with the addition of newer studies Supplementary File 2. Notably, statistically significant results for screening time increased with the addition of more studies Supplementary File 2. For a mean surgical time, the first statistically significant result appeared when Duan 2017 was added (p = 0.043) Supplementary File 2, while for a hospital stay, the first significant result was observed after including Zang 2018 (p = 0.024) Supplementary File 2. The time to healing showed a similar trend, with the first significant result appearing after adding Tian 2022 (p = 0.039) Supplementary File 2. In contrast, the results for femoral neck shortening, mean HHS, and PMS remained robust and unchanged across the cumulative evidence, suggesting consistency in these findings despite including new data Supplementary File 2.
3.8 Meta regression
In the meta-regression analysis examining the influence of mean age and sex (male), most outcomes showed no statistically significant associations with these variables. For age, a significant coefficient was observed only for mean surgical time (coefficient = 0.969, p = 0.001), suggesting that age may influence surgical duration, potentially extending it. Hospital stay also demonstrated significance with age (coefficient = 0.069, p = 0.000), indicating longer hospital stays with increasing age in this treatment context. For sex (male), a borderline significance was noted for patients needing blood transfusions (coefficient = 0.000175, p = 0.050), suggesting that the male sex might slightly impact transfusion requirements. However, all other associations between age or sex and the various outcomes were non-significant, indicating a limited influence of these demographic factors on the overall effect of IMN versus DHS across most outcomes. Supplementary File 2.
3.9 Trial Sequential Analysis (TSA)
The Trial Sequential Analysis (TSA) results provided critical insights into the robustness of the findings from the meta-analysis. For the outcome of open reduction of fractures, the analysis revealed a sample size of 1313 with a required information size (RIS) of 6977, indicating that the current evidence is insufficient to draw definitive conclusions, as the Z-curve did not reach the upper significance boundary or the futility boundary Supplementary File 2. Regarding blood loss, the TSA reached an RIS of 449, confirming that the accumulated sample size is adequate for evaluating the effectiveness of IMN compared to DHS in this outcome Supplementary File 2. However, for the time to healing, despite a sample size of 1325, the current cumulative sample is below the RIS of 2791, indicating a need for further research to strengthen the conclusions regarding the healing duration associated with each surgical method Supplementary File 2. Lastly, the analysis for femoral neck shortening presented a sample size of 1577 with a high RIS of 29494, suggesting that the evidence remains inconclusive, as the cumulative Z-score has not crossed any efficacy or futility boundary Supplementary File 2.
3.10 GRADE approach
The GRADE approach identified varying levels of evidence quality Table 2. All outcomes exhibited high heterogeneity (I² > 80%). For the outcome of open reduction of the fracture, evidence was rated as very low due to the inclusion of studies using diverse techniques of IMN. In contrast, the blood loss (ml) outcome received a high rating, indicating robust evidence; however, significant heterogeneity in effect estimates was noted. Additionally, there was evidence of publication bias, supported by a significant Egger test p-value of 0.0001. Conversely, time to healing and femoral neck shortening were rated as low, primarily due to high heterogeneity and small sample sizes relative to the required information size.
| Certainty assessment | № of patients | Effect | Certainty | Importance | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| № of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | IMN | DHS | Relative (95% CI) | Absolute (95% CI) | ||
| Open reduction of fracture | ||||||||||||
| 8 | RCTs = 6NRCTs = 2 | not serious | very seriousa | not seriousb | very seriousc,d | none | 86/697 (12.3%) | 115/616 (18.7%) | Log odds-ratio -1.52 (-3.31 to 0.28) | -- per 1,000 (from -- to --) | ⨁◯◯◯ Very lowa,b,c,d | IMPORTANT |
| Blood loose (ml) | ||||||||||||
| 29 | RCTs = 19NRCTs = 10 | not serious | not seriouse | not seriousb | not serious | publication bias strongly suspected very strong associationf | 2121 | 2004 | - | MD 98.8 ml lower (127.96 lower to 69.64 lower) | ⨁⨁⨁⨁ Highb,e,f | CRITICAL |
| Time to healing (days) | ||||||||||||
| 11 | RCTs = 5NRCTs = 6 | not serious | seriousa | not seriousb | seriousd | none | 659 | 666 | - | MD 6.92 days lower (12.55 lower to 1.29 lower) | ⨁⨁◯◯ Lowa,b,d | IMPORTANT |
| Femoral neck shortening (mm) | ||||||||||||
| 8 | RCTs | not serious | seriousa | not serious | seriousd | none | 759 | 782 | - | MD 1.19 mm lower (4.21 lower to 1.83 higher) | ⨁⨁◯◯ Lowa,d | IMPORTANT |
3.11 Publication bias
The results from the publication bias assessment, evaluated using Egger's test, indicate a significant publication bias for blood loss, with a p-value of 0.0001. This suggests that smaller studies with positive results are more likely to be published, which may skew the findings Supplementary File 2. In contrast, the mean surgical time also showed considerable evidence of bias, with a p-value of 0 Supplementary File 2. Other outcomes, including screening time, hospital stay, Time to Healing (in days) and Mean HHS yielded p-values of 0.2075, 0.1805, 0.1376, and 0.1467, respectively. These results suggest no significant evidence of publication bias for these outcomes Supplementary File 2.
Discussion
The results of this meta-analysis highlight several key findings regarding the comparative effectiveness of IMN versus DHS fixation in the management of trochanteric fractures. Notably, while there was no statistically significant difference in the open reduction of fractures, IMN demonstrated a significant reduction in intraoperative blood loss, indicating a clear advantage in minimizing hemorrhage. Additionally, IMN showed a trend towards requiring fewer blood transfusions, although this was not statistically significant. Surgical time favored IMN with a notable reduction, and patients undergoing IMN experienced a significant decrease in both hospital stay and time to healing. However, as measured by Harris hip scores and Parker Mobility scores, functional outcomes were comparable between both techniques, suggesting similar recovery trajectories despite differences in surgical parameters. Meta-regression analysis revealed limited associations between age and sex with most outcomes, although older age correlated with longer surgical times and hospital stays. While IMN presents advantages in terms of blood loss and recovery time, the high heterogeneity across outcomes and varying quality of evidence necessitate cautious interpretation of these findings.
Our findings are consistent with previous research concerning the comparative effectiveness of IMN and DHS in managing trochanteric fractures. Specifically, our meta-analysis, along with studies by Zeelenberg et al. (2024) (89) and Zeng et al. (2012) (90), demonstrates that IMN is associated with significantly reduced intraoperative blood loss and shorter surgical durations, highlighting its efficiency as a treatment modality. Furthermore, the functional outcomes observed in our study, as measured by metrics such as Harris Hip Scores, align with findings from Huang et al. (2013) (91) and Xu et al. (2022) (92). This suggests that, despite variations in surgical parameters, patients' recovery trajectories are comparable between both techniques. The convergence of evidence underscores the potential advantages of IMN in enhancing surgical efficiency and patient safety, thereby warranting further investigation into long-term outcomes and the optimization of surgical protocols for trochanteric fractures. Notably, Yu et al. (2023) (93) reported a significant reduction in intraoperative blood loss associated with IMN, as well as its effectiveness in preventing femoral neck shortening and reducing non-union rates. These findings align with our observations of fewer blood transfusions required for IMN, although this difference did not reach statistical significance.
Despite the overall alignment with existing literature, our study reveals several noteworthy discrepancies regarding healing time and length of hospital stay. Specifically, our results indicate a significant reduction in hospital stay and healing time associated with IMN, which contrasts with the findings reported by Huang et al. (2013), where no significant differences were observed between Proximal Femoral Nail Antirotation (PFNA) and DHS. This discrepancy may be attributed to variations in patient populations, surgical techniques, or postoperative care protocols across studies. Additionally, while Zhang et al. (2023) (94) acknowledge the advantages of PFNA over DHS in various postoperative outcomes, they also highlight areas where DHS demonstrated superior performance, particularly concerning hidden blood loss. Furthermore, Yu et al. (2023) did not identify significant differences in surgical time, hospital stays, or functional scores between the two techniques. Statistical analysis comparison between our study and the previous meta-analysis is presented in Table 3.
| Study ID | Studies included (N) | Subgroup analysis | Leave one out test | cumulative analysis | TSA | Meta-regression | GRADE |
|---|---|---|---|---|---|---|---|
| Our study | RCTs = 31 Cohort = 29 | Yes | Yes | Yes | Yes | Yes | Yes |
| Zeelenberg 2024 | RCTs = 14 Observational = 13 | No | No | No | No | No | No |
| Yu 2023 | RCTs = 30 | No | Yes | NO | No | No | No |
| Zhang 2023 | RCTs = 5 Observational = 12 | No | Yes | NO | No | No | No |
| Xu 2022 | RCTs = 12 | No | No | NO | No | No | Yes |
| Huang 2013 | RCTs = 8 | No | Yes | No | No | No | No |
| Zeng 2012 | RCTs = 13 | No | Yes | Yes | No | No | No |
Future research should prioritize longitudinal studies to evaluate the long-term functional recovery and complication rates associated with IMN and DHS techniques. It is essential to conduct high-quality RCTs that compare these procedures and their varied techniques to address the observed heterogeneity while controlling for variables such as fracture type and comorbidities. Cost-effectiveness analyses should also be performed to inform healthcare decision-making. Finally, exploring innovative fixation methods or modifying existing techniques may improve patient outcomes for those with trochanteric fractures.
Our study has several strengths that enhance the credibility of our findings. First, the comprehensive literature search conducted ensures a robust foundation for our analysis. Additionally, most of the included studies demonstrated high methodological quality, which further supports the reliability of our results. The large sample size significantly increases the statistical power of our findings, allowing for more generalizable conclusions. Moreover, by evaluating multiple outcomes, we provide a comprehensive overview of the effectiveness and safety of IMN compared to dynamic hip screw DHS fixation. Finally, the incorporation of Trial Sequential Analysis (TSA) adds an extra layer of rigor to our analysis, facilitating a thorough assessment of the robustness of our conclusions.
Also, we noted several points that limit the certainty of the evidence. The heterogeneity among the included studies may restrict the generalizability of our findings, as variations in study designs, patient populations, and surgical techniques could influence the outcomes. Additionally, we observed potential publication bias, especially concerning blood loss and mean surgical time. Some outcomes were constrained by insufficient sample sizes, and there was variability in follow-up durations across studies. The sensitivity analysis indicated that certain studies had a significant impact on specific outcomes, particularly regarding the open reduction of fractures and blood transfusions. Subgroup analysis Based on surgical techniques or fractures classifications was not applicable because there was not enough data.
In summary, our meta-analysis provides valuable evidence regarding the comparative effectiveness of IMN versus DHS in treating trochanteric fractures. While existing studies widely agree on the benefits of IMN in terms of reduced blood loss and improved surgical efficiency, discrepancies persist regarding healing times and length of hospital stays. Continued research is crucial to refining treatment strategies and determining the efficacy of various IMN techniques compared to different DHS approaches.